Wesana Health Holdings Inc. announced the addition of distinguished psychedelics researcher and professor, Rachel Yehuda, PhD, to its Scientific Advisory Board. In this role, Dr. Yehuda will provide strategic guidance and direction to Wesana’s scientific research efforts related to psychedelic-assisted psychotherapy and traumatic brain injury (TBI). She is also Director of the Traumatic Stress Studies Division at Icahn Mount Sinai which includes the PTSD clinical research program.